Reminiscences of a Cannabis Stock Trader (FUTL) Investor

New Post Public Reply Private Reply Replies (0) Message Board
canna-girl
1,244
Reminiscences of a Cannabis Stock Trader

Although the pioneer days of 1920s stock trading are long gone, some similarities exist with today's cannabis stock industry, the wild wild west of OTC stock trading.

Today, I'm profiling one of our stakeholders, Sal Tracey, a Florida-based military analyst by day and stock trader in between. Tracey joined the navy right after high school and spent two years in Washington DC working for Intergraph in Alexandria. He was introduced to investing while at NJVC, an IT services company for the defense industry. He started trading from his IRA account, learning the ropes with his company matching the funds, growing his account quickly.

He was then given the opportunity to have a self-directed brokerage account with Scottrade, so he started taking more risk, and trading in the small caps and OTC markets. This was where the fun began for Tracey, as he quickly learned the art of leveraging.

Tracey also learned some hard lessons too. He had invested a substantial sum in Washington Mutual (WAMU) stock in 2008, one of the leading sub-prime stocks to go under, and he almost lost everything. He kept trading, however, and soon got his rhythm back. In 2013, Tracey was introduced to the cannabis stock industry from a colleague who was an institutional investor.

Which cannabis companies did you start trading and why?

I first found Medbox (MDBX), a company offering vending machines to dispense cannabis using biometric technology. I made a killing with it, and was hooked!
I bought it at $17 and then sold some of it at $96, then started to look for other cannabis stock opportunities.

I came across Futureland Corp (FUTL) through a coworker who was an institutional investor in solar and marijuana stocks. I researched FUTL, and really liked what I saw, a "grow to blow" company that owned not only the cannabis being cultivated, but everything in between. I think this is where the industry is going, but FUTL had the vision to plan for this right from the start."
At what point did you really start to heavily invest in FUTL stock?

Probably when I found out they were a local Florida company, I set up an interview with Cameron Cox and Sam Talari, the co-owners. I had prepared a detailed list of questions--in my research of cannabis publicly traded companies, I had found a lot of fly-by-night companies with no real idea of how to grow cannabis, much less sell it on a large scale.

However, upon meeting with Cox and Talari, I was surprised to hear that they had planned for every contingency, and had a concrete strategic plan in place.

I wanted to invest more heavily in their stock, but my wife insisted that I not use my IRA or savings. I decided to sell my 2009 Honda Shadow motorcycle, so I started talking to the guys at the OTC Powersports Bike Shop in Tampa, asking them if they might have a buyer.

They asked a lot of questions about why I was selling my 2009 Honda Shadow, so I started telling them about Futureland Corp. Before I knew it, they were totally on board with buying FUTL stock, but still a bit leery because of the ambiguous status of the industry.

I also was upset with the unfair treatment they were receiving on the InvestorsHub investment site, which is very biased towards clueless traders with no idea how to run a startup company, much less a newly legalized cannabis company. I felt that a more honest objective opinion was in order, so I reached out to offer my personal experience as a trader with FUTL stock.

Which stocks are you holding in your portfolio right now, and why?

In my IRA account, I own mostly Sprint stock that I made a killing on last year when Softbank President Masayoshi Son started buying it up, and the stock went through the roof. I had bought it at $3-4 and sold it at $14-15, so was very happy with the sudden jump in my account.

I also own 67,000 shares of Frontier stock that I bought at $1.92, but has dropped to $1.34, so I'm down about 70k right now. They are doing a reverse split in July, so at that point, I plan to get out, as I made some decent money.

On my self-directed account, I only own two stocks, Medbox (MDBX) and Futureland Corp (FUTL), 3% Medbox and 97% Futureland Corp. Medbox had a very unique offering, a cannabis vending machine using biometrics, so in principal the idea was genius. However, they were investigated by the SEC in 2014 for falsely reporting most of their income.

I still own 100 shares of Medbox (MDBX) that I bought back at $4 stock, as they have now changed their name to Notis (NGBL). They hired a new team of directors, and have gone in a completely new direction, planting hemp (non-THC cannabis) in Pueblo County, Colorado.

I strongly believe in Insert-tag-hereFutureland Corp's potential. Their only weakness is that they can't report a revenue stream at this point, but neither can many of these cannabis startups for that matter.

It doesn't help that the current administration is not cannabis-friendly and inconsistent in its messaging about cannabis. This does nothing to soothe the public's fears that the industry just can't seem to get going.

Cameron told me that one of his biggest pet peeves is that cannabis smokers are still perceived as a bunch of "stoner losers". When in fact, white collar professionals are coming home at night, roll a joint, and just relax, in place of a glass of wine.

I still have faith in Futureland Corp and can't wait to sell my motorcycle so I can take advantage of these very affordable prices to buy up a ton of FUTL stock. My advice to them is to stick with their plan, and wait for the rest of the industry to catch up.

FutureLand Corp. (FUTL) Stock Research Links

FUTL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 2

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
AI and Workforce Transformation: Zellis Connect 2026

Updated Category News Views 0

AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 3

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Hyundai and UEFA: Kicking Off a Game-Changing Deal

Updated Category News Views 3

Hyundai Drives Into Europe's Football Arena Football fever just turned electric with Hyundai allying itself with the UEFA Champions League. We're not talking about sidelines. We're smack dab in the center field of a multi-year partnership starting with the 2026/27 season. Folks, if you think this is just Hyundai shaking hands for brand exposure, think again. This is...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 4

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 2

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
AION UT Sets New Safety Standard in Euro NCAP 2026

Updated Category News Views 1

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Continue Reading
Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 0

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading

Top 5 Most Recently Viewed Articles

Lynkwell Boosts Growth with Strategic Investments in North America

Updated Category News Views 191

Lynkwell Amplifies Growth Plans for North American Expansion Lynkwell, a leading player in energy infrastructure, is set to embark on an exciting journey into 2025. With a focus on meeting the growing demands of the evolving electric vehicle (EV) market, Lynkwell is making significant investments to enhance its capabilities and expand its footprint across North America....

Continue Reading
Understanding the Recent Private Student Loan Trends and Insights

Updated Category News Views 197

Overview of Recent Trends in Private Student Loans In the recent semi-annual Private Student Loan Report released by Enterval Analytics, insights into the current status of private student loans reveal a stable repayment landscape. Since Enterval focuses on the private student loan market, their findings shed light on how borrowers are adapting their financial strategies...

Continue Reading
StemCyte's Groundbreaking RMAT Designation for Long COVID-19

Updated Category News Views 63

StemCyte's Major Achievement in Cord Blood Therapy StemCyte has made significant strides in regenerative medicine, specifically with its Hematopoietic Progenitor Cell (HPC) Cord Blood therapy. The company recently announced that it has received the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) aimed at treating...

Continue Reading
Novo Nordisk Restructures to Combat Rising Competition

Updated Category News Views 214

Novo Nordisk's Significant Job Cuts Novo Nordisk, a leading pharmaceutical company in diabetes care, has announced a major workforce reduction, cutting 9,000 jobs, which amounts to about 11.5% of its employees. This decision reflects the intense market pressure the company faces from its competitor, Eli Lilly. Restructuring for Financial Efficiency The restructuring...

Continue Reading
One Helix: The Innovative Research Hub Transforming Life Sciences

Updated Category News Views 169

Elevating Research with One Helix One Helix emerges as a landmark project in life sciences, representing a new era of innovation and sustainable architecture. Located within a prominent university medical center, this facility is not just a building; it is a commitment to fostering scientific advancements. Completely leased to AstraZeneca, One Helix is designed to elevate...

Continue Reading